There was, however, significantly diminished survival associated with mucinous tumors harboring either BRAF mutations (HR 2.56, 95 %CI: 1.26–5.20, p = 0.01) or TP53 mutations (HR 1.65, 95 %CI: 1.04–2.62, p = 0.03). This evidence concerns the gene BRAF and mucinous neoplasm.